LTS Lohmann Therapie-Systeme AG
  1. Companies
  2. LTS Lohmann Therapie-Systeme AG
  3. Products
  4. LTS - Model Sorrel - Wearable OBDS for ...

LTSModel Sorrel - Wearable OBDS for Large Volume Drug Delivery

SHARE
The Sorrel Platform is a next-generation on-body delivery system (OBDS) engineered to handle large volume and highly viscous formulations. Tailored for both patients and pharmaceutical companies, the Sorrel OBDS is digitally integrated to provide enhanced data capture, aiding in better patient adherence and informed decision-making within the pharmaceutical ecosystem. The platform supports various configurations and accommodates different molecules and indications, ensuring effective and straightforward drug delivery at home. Key features include connectivity functions for product improvement, a wide range of available volumes from 1mL to over 50mL, and a primary-container-agnostic design that fits seamlessly into existing filling processes. The system is software-controlled for flexible infusion profiles and incorporates UV disinfection at the point-of-care for easy loading. Additionally, it utilizes electromechanical drug 'pulling' to protect sensitive biologics. Patients benefit from a user-friendly design that requires no handling of needles or drugs, with tactile, audio, and visual indicators providing reassurance for safe administration.
Most popular related searches

Sorrel™ Platform – A next generation on body delivery system (OBDS) for large volume and highly viscous formulations

Designed with both patient and pharma in mind, the Sorrel OBDS wearable platform is digitally integrated to deliver greater data for the pharma eco-system and enable better adherence for the patient.

Based on our patents and ground-breaking design, Sorrel™is suited for multiple configurations, molecules, and indications to enable smart, reliable, simple drug delivery at home.

Intuitive for the patient, our platform enables pharma partners to mitigate the risks associated with original development including safety, efficacy, cost and time to market.

  • Connectivity function to deliver product improvement and compliance data

  • Wide range of volumes available from 1mL to 50+ mL

  • Primary-container agnostic to fits seamlessly into established filling processes

  • Software-controlled for unlimited infusion profiles

  • Platform design reduces development time and cost, while enabling customer flexibility in development

  • Novel UV disinfection at point-of-care simplifies loading of primary container

  • Electromechanical ‘pulling’ of drug protects sensitive biologics

 
  • Designed to optimise patient experience and improve regimen adherence

  • Pre-filled and pre-loaded to make use easier for the user, simply peel, stick, initiate

  • No patient handling of needles nor drug

  • Reassurance in successful and safe administration enabled by tactile, audio, and visual smart indicators

  • Virtually-painless needle deployment for enhanced user-experience